News
After a second Elevidys patient death from acute liver failure, Sarepta in July launched a major restructuring that involves ...
Shares of Sarepta Therapeutics ( NASDAQ: SRPT) rose on Wednesday after the market as it reported second quarter revenue and ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
Sarepta Therapeutics hired a Trump-connected lobbying firm after the death of a teenage boy treated with its Duchenne ...
Sarepta Therapeutics (NASDAQ:SRPT) has hired a lobbying firm with close ties to the Trump administration as regulatory ...
Novartis has made a takeover approach for rare disease-focused biotech Avidity Biosciences, as Big Pharma continues to hunt ...
2h
Investor's Business Daily on MSNAvidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
Avidity Biosciences stock rocketed Wednesday on a report Novartis made an attempt to buy the rare disease-focused biotech ...
22h
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own Medicine
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
7hOpinion
The New Republic on MSNPete Hegseth Unveils Return of Pro-Slavery Monument
U.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be reinstalled in Arlington Cemetery ...
Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.
9hOpinion
The New Republic on MSNIs Trump About to Drag Joe Rogan Into the Epstein Files Debacle?
The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
Dr Vinay Prasad was asked to step down as the FDA's top vaccine official following several controversies during his brief tenure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results